Search
GT Biopharma Inc
GTBPAdd to Watchlist
0.490USD
+0.050+11.30%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
17.66MMarket Cap
LossP/E TTM
GT Biopharma Inc's Company Valuation
Currency: USD Updated: 2026-06-30The current valuation score of GT Biopharma Inc is 7.71, ranking 198 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.08, which is -87.44% below the recent high of -0.01 and -1873.15% above the recent low of -1.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
